Results 241 to 250 of about 280,195 (357)

Brentuximab vedotin and radiotherapy for CD30‐positive cutaneous T‐cell lymphoma – a retrospective multicenter analysis

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives While brentuximab vedotin (BV) and radiotherapy (RTx) are established treatment options for CD30‐positive cutaneous T‐cell lymphoma (CTCL), data on their simultaneous or sequential use regarding efficacy and tolerability remain scarce.
Patrick Schummer, Caroline Glatzel, Philipp Schrüfer, Ingulf Lawrenz, Gabor Dobos, Ulrike Wehkamp, Svea Hüning, René Stranzenbach, Jan P. Nicolay, Matthias Goebeler, Marion Wobser   +10 more
wiley   +1 more source

Minimally invasive liquid biopsy analysis of B-cell non-Hodgkin lymphomas

, 2018
Laura S. Jiwa
openalex   +1 more source

Non-Hodgkin Lymphoma of the jejunum presenting as perforation peritonitis: A case report

, 2020
Warsinggih Warsinggih, Suluh Darmadi, Prihantono Prihantono, Muhammad Faruk   +3 more
openalex   +1 more source

Modeling Gene-Environment Interaction for the Risk of Non-hodgkin Lymphoma [PDF]

, 2019
Jiahui Zhang, Xibiao Ye, Cuie Wu, Hua Fu, Wei Xu, Pingzhao Hu   +5 more
openalex   +1 more source

New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy

Expert Review of Anticancer Therapy, 2015
Dai Chihara, L. Nastoupil, Jessica N. Williams, Paul Lee, J. Koff, C. Flowers   +5 more
semanticscholar   +1 more source

First‐line tagraxofusp induces durable responses with prolonged survival in adults younger than 50 years with blastic plasmacytoid dendritic cell neoplasm: Post hoc analysis of a phase 2 trial

British Journal of Haematology, EarlyView.
Anthony S. Stein, Andrew A. Lane, Kendra L. Sweet, Sumithira Vasu, Alessandra Tosolini, John Katsetos, Marina Konopleva, Naveen Pemmaraju   +7 more
wiley   +1 more source

Persistent Respiratory Symptoms Post-COVID-19 in a Non-Hodgkin Lymphoma Patient: A Case Report. [PDF]

Cureus
Dimeas IE, Papra S, Dimeas G, Pantazopoulos I, Daniil Z.   +4 more
europepmc   +1 more source

Comparison of the impact of cancer between British and US long-term non-Hodgkin lymphoma survivors

, 2016
Shah-Jalal Sarker, Sophia K. Smith, Kashfia Chowdhury, Patricia A. Ganz, Sheryl Zimmerman, John G. Gribben, Ania Korszun   +6 more
openalex   +1 more source

Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma.

Journal of Clinical Oncology, 2015
J. Gribben, N. Fowler, F. Morschhauser
semanticscholar   +1 more source

Role of remdesivir for the treatment of COVID‐19 in patients with hematologic malignancy—A narrative review and expert opinion

European Journal of Clinical Investigation, EarlyView.
Created in BioRender. Ghezzi, S. (2025) https://BioRender.com/q1lticg. Abstract Background COVID‐19 remains a potentially severe condition for immunocompromised individuals, such as patients with hematologic malignancy. These patients are at increased risk of progressing to severe–critical or prolonged COVID‐19.
Malgorzata Mikulska, Matteo Bassetti, Alessandro Busca, Valeria Cento, Maddalena Giannella, Michele Bartoletti   +5 more
wiley   +1 more source